Earlier studies have already demonstrated variability in the lifetime risks of developing CRC among different individuals with LS, with carriers of a gPV in MLH1 and MSH2 being at the highest hereditary CRC risk [16]. The gene discussed is MSH2; the disease is colorectal carcinoma.